Regen BioPharma Inc (RGBP)
0.66
+0.09
(+15.79%)
USD |
OTCM |
May 03, 16:00
Regen BioPharma Free Cash Flow (Quarterly): -0.2093M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.2093M |
December 31, 2023 | -0.1623M |
September 30, 2023 | -0.0234M |
June 30, 2023 | -0.087M |
March 31, 2023 | -0.053M |
December 31, 2022 | -0.0105M |
September 30, 2022 | -0.0853M |
June 30, 2022 | -0.1237M |
March 31, 2022 | -0.1188M |
December 31, 2021 | -0.2791M |
September 30, 2021 | -1.067M |
June 30, 2021 | -0.0639M |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.0057M |
December 31, 2019 | 0.0243M |
September 30, 2019 | -0.137M |
June 30, 2019 | -0.0673M |
March 31, 2019 | -0.1275M |
Date | Value |
---|---|
December 31, 2018 | -0.15M |
September 30, 2018 | -0.4656M |
June 30, 2018 | -0.0814M |
March 31, 2018 | -0.4035M |
December 31, 2017 | -0.6273M |
September 30, 2017 | -0.623M |
June 30, 2017 | -0.4172M |
March 31, 2017 | -0.3499M |
December 31, 2016 | -0.5043M |
September 30, 2016 | -0.3985M |
June 30, 2016 | -0.4109M |
March 31, 2016 | -0.4375M |
December 31, 2015 | -0.4254M |
September 30, 2015 | -0.339M |
June 30, 2015 | -0.3884M |
March 31, 2015 | -0.2682M |
December 31, 2014 | -0.1971M |
September 30, 2014 | -0.1904M |
June 30, 2014 | -0.1684M |
March 31, 2014 | -0.195M |
December 31, 2013 | -0.1931M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.067M
Minimum
Sep 2021
0.0243M
Maximum
Dec 2019
-0.1234M
Average
-0.0656M
Median
Free Cash Flow (Quarterly) Benchmarks
CervoMed Inc | -2.538M |
GlucoTrack Inc | -2.411M |
AIM ImmunoTech Inc | -9.956M |
Protalix BioTherapeutics Inc | 3.345M |
Armata Pharmaceuticals Inc | -10.51M |